tiprankstipranks
Cypherpunk Technologies Inc. (CYPH)
NASDAQ:CYPH
Want to see CYPH full AI Analyst Report?

Cypherpunk Technologies (CYPH) Price & Analysis

991 Followers

CYPH Stock Chart & Stats

$0.98
$0.01(1.03%)
--

Bulls Say, Bears Say

Bulls Say
Low LeverageExtremely low reported leverage gives the company durable financial flexibility to fund operations, R&D or strategic moves without immediate refinancing pressure. This capital buffer lowers bankruptcy risk and supports multi-month runway despite weak operations, a lasting structural strength.
Stronger Equity BaseA materially larger equity and asset base and a reported ROE improvement provide a stable capital foundation, enabling investment or acquisition optionality. This expanded equity position reduces reliance on external debt and preserves strategic choices over the coming quarters.
Orderly Board RefreshPlanned, amicable board retirements signal a managed governance transition rather than crisis. A deliberate refresh can bring new expertise and strategic focus, improving oversight and execution over the medium term without the disruption of abrupt leadership departures.
Bears Say
Revenue CollapseRevenue at or near zero removes internal funding for operations and undermines commercial traction and market validation. Sustained lack of top-line growth forces dependence on capital sources and raises long-term questions about business viability and ability to scale revenue.
Persistent Cash BurnMaterial negative operating and free cash flows show the company cannot self-fund operations. Continued cash burn erodes reserves over months, creating ongoing dilution or financing needs that materially constrain strategic choices and threaten sustainability absent revenue recovery.
Listing Compliance RiskA Nasdaq minimum bid deficiency creates a structural governance and liquidity risk: potential reverse splits, additional administrative costs, and delisting prospects. That listing uncertainty can impair access to capital, employee incentives, and long-term investor confidence.

Cypherpunk Technologies News

CYPH FAQ

What was Cypherpunk Technologies Inc.’s price range in the past 12 months?
Cypherpunk Technologies Inc. lowest stock price was $0.23 and its highest was $3.70 in the past 12 months.
    What is Cypherpunk Technologies Inc.’s market cap?
    Cypherpunk Technologies Inc.’s market cap is $88.52M.
      When is Cypherpunk Technologies Inc.’s upcoming earnings report date?
      Cypherpunk Technologies Inc.’s upcoming earnings report date is May 18, 2026 which is in 13 days.
        How were Cypherpunk Technologies Inc.’s earnings last quarter?
        Cypherpunk Technologies Inc. released its earnings results on Mar 16, 2026. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of -$0.066 by $0.986.
          Is Cypherpunk Technologies Inc. overvalued?
          According to Wall Street analysts Cypherpunk Technologies Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Cypherpunk Technologies Inc. pay dividends?
            Cypherpunk Technologies Inc. does not currently pay dividends.
            What is Cypherpunk Technologies Inc.’s EPS estimate?
            Cypherpunk Technologies Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cypherpunk Technologies Inc. have?
            Cypherpunk Technologies Inc. has 89,979,620 shares outstanding.
              What happened to Cypherpunk Technologies Inc.’s price movement after its last earnings report?
              Cypherpunk Technologies Inc. reported an EPS of $0.92 in its last earnings report, beating expectations of -$0.066. Following the earnings report the stock price went up 12.642%.
                Which hedge fund is a major shareholder of Cypherpunk Technologies Inc.?
                Currently, no hedge funds are holding shares in CYPH
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Cypherpunk Technologies Inc.

                  Cypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. The company was incorporated in 2011 and is based in Cambridge, Massachusetts.

                  Cypherpunk Technologies (CYPH) Earnings & Revenues

                  Ownership Overview

                  2.76%2.51%0.13%92.60%
                  0.13% Other Institutional Investors
                  92.60% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks